🇫🇷
France · FR · FR:69731801
ZENTEL 0,4 g/10 mL, suspension buvable
ReimbursedATC P02CA03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerGLAXOSMITHKLINE
CountryFR (France)
ATC codeP02CA03
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009329704141 flacon(s) polyéthylène haute densité (PEHD) de 10 mlEUR 3.01
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "69731801",
"date_amm": "1987-07-01",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code P02CA03.
- CZALBENDAZOL VIM SPECTRUM
- 🇺🇸AlbendazoleAmneal Pharmaceuticals of New York LLC
- 🇺🇸AlbendazoleDr.Reddys Laboratories Inc
- 🇺🇸AlbendazoleAlembic Pharmaceuticals Limited
- 🇺🇸AlbendazoleActavis Pharma, Inc.
- 🇺🇸AlbendazoleAlembic Pharmaceuticals Inc.
- 🇺🇸AlbendazoleNovadoz Pharmaceuticals LLC
- 🇺🇸AlbendazoleEdenbridge Pharmaceuticals LLC.
Access this data programmatically
Query ZENTEL 0,4 g/10 mL, suspension buvable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.